Objective To assess the efficacy and safety of tocilizumab plus methotrexate (MTX) versus
MTX alone in preventing structural joint damage and improving physical function and disease …

Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …

… Marek Brzosko4, … PM, MB, PW, SG-U, HM, Y-AL, SS, M-JL, VK and CA-M were involved
in the acquisition of data, drafting of the manuscript and revising it critically for important …

Evidence from over 10 years of clinical experience demonstrates that biosimilar medicines
approved in the European Union can be used for all their registered indications as safely as …

Clonal expansion of CD4 + CD28 - T cells is a characteristic finding in patients with rheumatoid
arthritis (RA). Expanded CD4 + clonotypes are present in the peripheral blood, infiltrate …

… Przepiera-Będzak H, Brzosko I, Brzosko M. Skeletal changes during the course of
pustulosis palmoplantaris – report of two cases. Pol Arch Med Wewn 2002; 107: 59-62. …

Biological drugs revolutionized the treatment of inflammatory rheumatic diseases. Access to
treatment presents substantial variability across Europe. The economic level of a particular …

… M. Brzosko has received lecture/instructor fees from Roche, Abbott, Amgen, Pfizer, MSD,
Novartis, Schering-Plough, and Sanofi-Aventis. R. Burgos-Vargas has received research grants …

… Hanna Przepiera-Będzak and Marek Brzosko conceived the idea for the study, contributed
to the design of the research, were involved in data collection, and analyzed the data. Hanna …

Introduction Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive
fibrosis of the skin and internal organs, leading to their failure and disturbances in the …